RIGEL PHARMACEUTICALS INC (RIGL) › Net IncomeRIGEL PHARMACEUTICALS INC (RIGL) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$51.46M2016: -$69.22M2017: -$77.99M2018: -$70.48M2019: -$66.89M2020: -$29.74M2021: -$17.91M2022: -$58.57M2023: -$25.09M2024: $17.48M2025: $367.02M$367.02M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$367.02M+1999.1%2024$17.48M+169.7%2023-$25.09M+57.2%2022-$58.57M-227.0%2021-$17.91M+39.8%2020-$29.74M+55.5%2019-$66.89M+5.1%2018-$70.48M+9.6%2017-$77.99M-12.7%2016-$69.22M-34.5%2015-$51.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share